An analysis of methods to prevent peritoneal dialysis catheter infections

Peritoneal Dialysis International

Volumn 28, Issue 5, 2008, Pages 437-443

  Piraino, Beth ^a   Bernardini, Judith ^a   Bender, Filitsa H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FUSIDATE SODIUM; GENTAMICIN; OFLOXACIN; PLACEBO; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CATHETER INFECTION; CLEANING; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST EFFECTIVENESS ANALYSIS; CYTOTOXICITY; DRUG EFFICACY; EXIT SITE INFECTION; HUMAN; MULTIPLE CYCLE TREATMENT; NOSE SMEAR; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; ARTICLE; INDWELLING CATHETER; META ANALYSIS; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CATHETERS, INDWELLING; HUMANS; MUPIROCIN; PERITONEAL DIALYSIS; PERITONITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 58249090713     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800502     Document Type: Review

References (25)

1. Piraino B, Bernardini J, Sorkin M. The influence of peritoneal catheter exit site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 6:436-40.
2. Gupta B, Bernardini J, Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 1996; 28:415-19.
3. Luzar MA, Coles GA, Faller B, Slingeneyer A, Dah Dah G, Briat C, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322:505-9.
4. Lye WC, Leong SO, van der Straaten J, Lee EJC. Staphylococcus aureus CAPD-related infections are associated with nasal carriage. Adv Perit Dial 1994; 10:163-5.
5. Swartz R, Messana J, Starmann B, Weber M, Reynolds J. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc of Nephrol 1991; 2:1085-91.
6. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M, et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18:225-31.
7. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27:695-700.
8. The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 11:2403-8.
9. Davey P, Craig A, Hau C, Malek M. Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized placebo-controlled trial. J Antimicrob Chemother 1999; 43:105-12.
10. Amato D, Ventura M, Miranda G, Leanos B, Alcantara G, Hurtado M, et al. Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kidney Dis 2001; 37:43-8.
11. Vychytil A, Lorenz M, Schneider B, Horl W, Haag-Weber M. New strategies to prevent Staphylococcus aureus infection in peritoneal dialysis patients. J Am Soc Nephrol 1998; 9:669-76.
12. Herwaldt LA, Boyken LD, Coffman S, Hochstetler, Flanigan MJ. Sources of Staphylococcus aureus for patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2003; 23:237-41.
13. Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 2003; 23: 456-9.
14. Bernardini J, Bender F, Florio T, Sloand J, PalmMontalbano L, Fried L, et al. Randomized double blinded trial of peritoneal dialysis exit site mupirocin 2% versus gentamicin sulfate 0.1% cream. J Am Soc Nephrol 2005; 16:539-45.
15. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-31.
16. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Garcia-Falcon T, Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients on peritoneal dialysis. Am J Kidney Dis 2002; 39:337-41.
17. Annigeri R, Conly, Vas SI, Dedier H, Prakashan KP, Bargman JM, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21:554-9.
18. Danguilan RA, Evangelista LP, Abrenica MS, Rondilla SM. Comparative study of mupirocin and sodium fucidate in the prophylaxis of exit-site infections in CAPD patients. Perit Dial Int 2003; 23:593-5.
19. Cavdar C, Zeybel M, Atay T, Sifil A, Sanlidag C, Gulay Z, et al. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis - first 6 months' experience. Adv Perit Dial 2004; 20:62-6.
20. Sesso R, Parisio K, Dalboni A, Rabelo T, Barbosa D, Cendoroglo M, et al. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1994; 41:370-6.
21. Luzar MA, Brown CB, Balf D, Hill L, Issad B, Monnier B, et al. Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicentered trial. Perit Dial Int 1990; 10:25-9.
22. Waite NM, Webster N, Laurel M, Johnson M, Fong IW. The efficacy of exit site povidone-iodine ointment in the prevention of early peritoneal dialysis related infections. Am J Kidney Dis 1997; 29:763-8.
23. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata E. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37:1629-38.
24. Strippoli GFM, Tong FM, Johnson AD, Schena F, Craig J. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 2004; 44:591-603.
25. Chu KH, Choy WY, Cheung CCW, Fung KS, Tang HL, Lee W, et al. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int 2008; 28:505-8.